ArcHealth Foundation, Merck for Mothers Read More
Search
Merck
Women’s Voices Reveal a Maternal Medicines Access Gap
Merck for Mothers Read More
Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season
Merck Read More
Merck’s Pneumococcal Shot Shows Promise in At-Risk Children & Teens
Merck Read More
2025 STAT Summit
Join the 2025 STAT Summit to explore the scientific, policy, and industry transformations set to shape the next decade in health and medicine, with insights from leading researchers, innovators, and decision-makers.
Indonesia to Be Vaccine Self-Sufficient by 2037, Says Health Minister
Merck Read More
The Fourth Trimester: A Crucial Phase for Women’s Health
Merck for Mothers Read More
Maternity Matters: Advancing Quality Care for All Through Healthy Beginnings and Healthy Futures
Join Devex and partners on May 21 in Geneva or online for Maternity Matters, a conversation on improving maternal and newborn survival through stronger health systems and collective global action.
US Government Researchers Present ‘Phenomenal’ New Data on HPV Vaccines
Merck Read More
A Blueprint for Change: Safer Childbirth Starts in the Community
Merck for Mothers Read More
Merck for Mothers Partners with Baby2Baby to Deliver Thousands of Vital Supply Kits to New Moms Across the US
Merck for Mothers Read More
Merck Plans to Launch US Subcutaneous Version of Keytruda on October 1
Merck Read More
Improving Maternal Health Across Asia Pacific, China & Japan
Merck for Mothers Read More
Access to Emergency Medical Services: A Critical Factor in Reducing Maternal Deaths
Merck for Mothers Read More
Merck Expands Commitment to Maternal Health Through Latest Round of Global Grants
Merck for Mothers Read More
FP Health Forum | UNGA79
Join Foreign Policy and supporting partners Seed Global Health, Merck, and more for the FP Health Forum at UNGA79. The Health Forum will bring together world leaders, policymakers, industry experts, and civil society to explore strategies for expanding healthcare access and improving system resilience. This forum features three sessions (Session One: Navigating the Climate-Health Nexus, Session Two: People-Centered Treatment and Prevention, Session Three: Global Solutions to Emerging Global Threats) focused on turning insights into action, and culminates in a special session on antimicrobial resistance.
The 2030 agenda: Sustainably accelerating maternal health outcomes | Devex Summit | UNGA79
Join Alliance member Merck for Mothers in partnership with Devex for the session, The 2030 agenda: Sustainably accelerating maternal health outcomes, on September 24th at the Devex Summit on the sidelines of UNGA79, which will spotlight the ongoing work to strengthen systems for safer childbirth, or S3C, and the vital role of public and private sector partnerships in advancing maternal health. Emphasizing real-world impacts and personal stories, this discussion will help you understand the achievements and learnings from S3C coalitions over the past two years and how these collaborations have innovated and scaled solutions that can help achieve WHO’s resolution to accelerate efforts in reducing maternal and child mortality.
Practicalities of Partnership Building | Concordia | UNGA79
Join Alliance member Merck at the 2024 Concordia Annual Summit happening in NYC during UNGA79 for the Practicalities of Partnership Building session on September 23, 2024 from 3:30 PM – 4:45 PM ET. The P3 Impact Award was created by Concordia, the University of Virginia Darden School Institute for Business in Society, and the U.S. Department of State’s Office of Global Partnerships to recognize and honor leading public-private partnerships (P3s) that improve communities and the world. This Strategic Dialogue is the public presentation and final evaluation of the five 2024 P3 Impact Award Finalists, and connects trends and partnering best practices to tangible global partnerships delivering impact around the world.
UNGA 79 and Climate Week | Acting Together to Shape the Development of Our Future, Alliance Members Gather in NYC
In September 2024, the United Nations General Assembly will convene in New York to confront complex global challenges during its 79th session (UNGA 79). Included in the high-level agenda is the Summit of the Future, as well as High-Level Meetings on antimicrobial resistance (AMR) and the existential threats posed by sea-level rise. In parallel, Climate Week will bring together over 600 events and activities across NYC, with Nature, Food Systems and Health as a key theme. The Bay Area Global Health Alliance and many of its members will be in NYC to take part in the action that is shaping the development of our future.
Merck’s RSV shot helps protect infants in mid-to-late stage study
Merck Read More